Cargando…
Multi‐organs perioperative immune‐related adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with NSCLC
The safety of neoadjuvant chemoimmunotherapy before surgery in patients with non–small cell lung cancer (NSCLC) remains unclear in the perioperative stage. We describe a case of a 63‐year‐old man with IIIC stage NSCLC who received neoadjuvant chemoimmunotherapy and radical lobectomy. After the secon...
Autores principales: | Xu, Yuan, Lyu, Xiaohong, Qin, Yingzhi, Ma, Dongjie, Wang, Mengzhao, Shi, Juhong, Long, Yun, Tang, Bo, Liu, Hongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376172/ https://www.ncbi.nlm.nih.gov/pubmed/35815431 http://dx.doi.org/10.1111/1759-7714.14567 |
Ejemplares similares
-
Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary team
por: Ma, Dongjie, et al.
Publicado: (2022) -
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?
por: Xu, Yuan, et al.
Publicado: (2023) -
Sarcoidosis‐like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response
por: Shi, Yuequan, et al.
Publicado: (2021) -
A pulmonary nodule mislocated in “dorsal” segment due to tri-lobed left lung
por: Lyu, Xiaohong, et al.
Publicado: (2023) -
Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
por: Yi, Chengxiang, et al.
Publicado: (2019)